Cargando…

TROPONIN-I PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS AND RISK OF MORTALITY IN COVID-19 PATIENTS

Detalles Bibliográficos
Autores principales:	Patel, Chirag, Ikram, Farukh, Nguyen, Nicholas, Nguyen, Hao, Ukoha, Chijioke, Hoang, Lawrence, Acharya, Priyanka, Sidhu, Manavjot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2021
Materias:	Spotlight on Special Topics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091430/ http://dx.doi.org/10.1016/S0735-1097(21)04533-2

Ejemplares similares

ELEVATED INTERLEUKIN-6 LEVELS IN COVID-19-INFECTED PATIENTS ARE ASSOCIATED WITH MAJOR ADVERSE CARDIAC EVENTS AND/OR MORTALITY
por: Nguyen, Nicholas, et al.
Publicado: (2021)

Relation of interleukin-6 levels in COVID-19 patients with major adverse cardiac events
por: Nguyen, Nicholas, et al.
Publicado: (2021)

ATRIAL FIBRILLATION AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG HOSPITALIZED COVID-19 PATIENTS
por: Aten, Kristopher, et al.
Publicado: (2022)

BRADYARRHYTHMIAS AND MORTALITY IN COVID-19 PATIENTS
por: Hoang, Lawrence, et al.
Publicado: (2021)

EFFECTS OF ELEVATED TROPONIN ON MORTALITY IN HOSPITALIZED COVID-19 PATIENTS WITH AND WITHOUT CORONARY ARTERY DISEASE
por: Zhao, Yi, et al.
Publicado: (2022)

BODY MASS INDEX AS A PREDICTOR OF MORTALITY IN PATIENTS ADMITTED WITH COVID-19, A RETROSPECTIVE STUDY
por: Abualfoul, Mujahed, et al.
Publicado: (2022)

SOCIAL DETERMINANTS OF MORTALITY FROM COVID-19, A RETROSPECTIVE STUDY OF 6,000 PATIENTS
por: Abualfoul, Mujahed, et al.
Publicado: (2022)

AGE AS A PREDICTOR OF MORTALITY IN PATIENTS ADMITTED WITH COVID-19, A RETROSPECTIVE STUDY OF 6,000 PATIENTS
por: Abualfoul, Mujahed, et al.
Publicado: (2022)

ATRIAL FIBRILLATION AND MORTALITY IN COVID-19 PATIENTS
por: Wang, Lucas, et al.
Publicado: (2022)

CRITICALLY ILL COVID-19 PATIENTS AND THERAPEUTIC ANTICOAGULATION WITH HEPARIN
por: Vu, Michael, et al.
Publicado: (2022)

PREDICTIVE VALUE OF TROPONIN, NTPROBNP AND SODIUM ON ADVERSE CLINICAL OUTCOMES IN COVID-19
por: Roman, Aida, et al.
Publicado: (2021)

INCIDENCE OF MAJOR ADVERSE CARDIAC EVENTS AT 6-MONTHS FOLLOW-UP IN COVID-19 POSITIVE VERSUS COVID-19 NEGATIVE PATIENTS
por: Arman, Huseyin Emre, et al.
Publicado: (2023)

TROPONIN CORRELATES WITH INFLAMMATORY MARKERS IN COVID-19
por: Klinkhammer, Brent, et al.
Publicado: (2021)

INITIAL, MAXIMUM, AND DELTA TROPONIN AND MORTALITY IN COVID-19
por: Go, Ronaldo, et al.
Publicado: (2021)

INITIAL TROPONIN LEVEL AND ECHOCARDIOGRAPHIC FINDINGS IN SEVERE COVID-19
por: Kumar, Sant, et al.
Publicado: (2021)

CLINICAL IMPACT AND PREDICTORS OF TROPONIN ELEVATION IN PATIENTS WITH COVID-19
por: Case, Brian, et al.
Publicado: (2021)

INITIAL TROPONIN LEVEL AS A COVID-19 ILLNESS PROGNOSTICATOR
por: Ruge, Max, et al.
Publicado: (2021)

COVID-19 AND HEART: ASSESSMENT OF TROPONIN AND CARDIOVASCULAR COMORBIDITIES AS PROGNOSTIC MARKERS IN PATIENTS HOSPITALIZED FOR COVID-19 IN A TERTIARY CENTER IN BRAZIL
por: Pinesi, Henrique, et al.
Publicado: (2022)

HIGH-SENSITIVITY CARDIAC TROPONIN T FOR THE DETECTION OF MYOCARDIAL INJURY AND RISK STRATIFICATION IN COVID-19
por: De Michieli, Laura, et al.
Publicado: (2021)

CLINICAL OUTCOMES AND PREDICTORS OF COVID-19 PATIENTS WITH TROPONIN ELEVATION AND CONCOMITANT RENAL DYSFUNCTION
por: Case, Brian, et al.
Publicado: (2021)

TROPONIN ELEVATION AS A MANIFESTATION OF COVID-19 MYOCARDIAL INFLAMMATION ASSOCIATED WITH INCREASED MORTALITY
por: Limaye, Sneha, et al.
Publicado: (2022)

TROPONIN, ANTICOAGULATION, ATRIAL FIBRILLATION AND CORONAVIRUS DISEASE 19 IN PATIENTS WITH UNDERLYING CARDIAC DISEASE
por: Limani, Saurabhkumar M., et al.
Publicado: (2023)

PERSONALIZING THE OPTIMAL CARDIAC TROPONIN THRESHOLD FOR COVID-19 PROGNOSTICATION BASED ON PRE-EXISTING COMORBIDITIES
por: Ruge, Max, et al.
Publicado: (2022)

PROGNOSTIC VALUE OF ELEVATED HIGH-SENSITIVITY TROPONIN LEVEL IN COVID-19 ASSOCIATED HOSPITALIZATIONS IN THE SOUTH BRONX
por: Yue, Bing, et al.
Publicado: (2021)

COMPARISON OF PROGNOSTIC SIGNIFICANCE OF TROPONIN I ELEVATION TO OTHER BIOMARKERS IN PATIENTS HOSPITALIZED WITH COVID 19 INFECTION
por: Jayanna, Manju Bengaluru, et al.
Publicado: (2021)

TROPONIN ELEVATION AS A PREDICTOR FOR OUTCOMES OF PATIENTS DIAGNOSED WITH COVID 19 INFECTION IN A LARGE PUBLIC HOSPITAL IN THE CHICAGO AREA
por: Quelal, Karol, et al.
Publicado: (2021)

RELATIONSHIP BETWEEN ADMISSION TROPONIN AND OUTCOMES IN CRITICALLY ILL PATIENTS WITH HEART DISEASE AND COVID-19 IN A TERTIARY CENTER IN BRAZIL
por: Moreira, Eduardo, et al.
Publicado: (2022)

AORTIC VALVE PROSTHESES, ICDS, AND CORONARY DRUG-ELUTING STENTS: CHANGES IN REPORTED RATES OF ADVERSE EVENTS DURING THE COVID-19 PANDEMIC
por: Zhou, Elsa, et al.
Publicado: (2022)

CHARACTERIZATION OF THE FIRST 391 REPORTS OF MYOCARDITIS AFTER MRNA COVID-19 VACCINES SUBMITTED TO THE VACCINE ADVERSE EVENT REPORTING SYSTEM - UNITED STATES
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2022)

A SYSTEMATIC REVIEW AND META ANALYSIS OF THE EVIDENCE FROM THE PUBLISHED CASE REPORTS AND VACCINE ADVERSE EVENTS REPORTING SYSTEMS FOR THE MYOCARDITIS FOLLOWING COVID-19 VACCINATION
por: Mehta, Ashwani, et al.
Publicado: (2022)

RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH COVID-19 INFECTION: A META-ANALYSIS
por: Mazur, Jan, et al.
Publicado: (2021)

SITE-LEVEL VARIABILITY IN THE PROCESSES OF CARE OVER TIME AMONG PATIENTS WITH COVID-19 AND ELEVATED TROPONIN: INSIGHTS FROM THE AMERICAN HEART ASSOCIATION'S CVD COVID-19 REGISTRY
por: Sammour, Yasser, et al.
Publicado: (2022)

CARDIOVASCULAR PREDICTORS OF ADVERSE OUTCOMES IN RACIALLY DIVERSE PATIENTS DIAGNOSED WITH COVID-19 INFECTION - AN EARLY, INNER CITY EXPERIENCE
por: Quelal, Karol, et al.
Publicado: (2021)

COVID-19 PANDEMIC STRESS CAN TRIGGER ACUTE CARDIOVASCULAR EVENTS IN NON-INFECTED INDIVIDUALS
por: Hammoudeh, Ayman J., et al.
Publicado: (2021)

SERUM BIOMARKERS HS-TNI AND SST-2 PREDICT LONG-TERM RISK FOR CARDIOVASCULAR EVENTS IN DISCHARGED HOSPITALIZED COVID-19 SURVIVORS
por: Zagidullin, Naufal, et al.
Publicado: (2023)

CARDIAC COMPLICATIONS FOLLOWING REPEATED DOSES OF COVID-19 VACCINES: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Le, Trang Thi Bich, et al.
Publicado: (2023)

CORONARY ARTERY CALCIFICATION HERALDS ADVERSE CLINICAL OUTCOMES IN PATIENTS HOSPITALIZED FOR COVID-19
por: Shabbir, Muhammad Asim, et al.
Publicado: (2021)

CLINICAL PREDICTORS OF COAGULOPATHY EVENTS IN HOSPITALIZED PATIENTS WITH COVID-19 DISEASE
por: Derbas, Laith, et al.
Publicado: (2021)

PREVALENCE AND OUTCOMES OF CARDIOVASCULAR COMPLICATIONS AMONGST COVID-19 PATIENTS
por: Aedma, Surya Kiran, et al.
Publicado: (2021)

NATIONWIDE TEMPORAL EVOLUTION OF PRE-HOSPITAL CARDIAC EVENTS DURING THE COVID-19 PANDEMIC
por: Shekhar, Aditya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mccmgbsc4dhcj5aqhs359840ld